BSECompany Update6d ago · 14 Aug 2026, 01:05 pm

Board of Directors of the Company in its meeting held on Friday, 14th August, 2026 at 11.45 A.M. approved and passed the resolution for allotment of Equity Shares on conversion of 7,86,690 ....

Godavari Drugs Ltd · 530317

✦ AI SummaryFundraise

Godavari Drugs Ltd has announced the allotment of 7,86,690 equity shares on conversion of warrants to promoters at an issue price of Rs. 89/- each, increasing the paid-up equity capital from Rs. 10,12,74,350/- to Rs. 10,91,41,250/-.

Analysis Scores

Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Godavari Drugs Ltd - 530317 - Announcement under Regulation 30 (LODR)-Allotment

Attachments (1)

📄

ddf2247a-0085-4c31-b669-16ba5bab7728.pdf

pdf

Download →
View document text
GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. To, Date: 14.08.2026 BSE Limited, P.J. Towers, Dalal Street, Mumbai – 400001 Dear Sir/Madam Unit: Godavari Drugs Limited (Scrip Code: 530317) Sub: Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements Regulations, 2015, we wish to inform the Exchanges that the Board of Directors of the Company in its meeting held on Friday, 14th August, 2026 at 11:45 A.M. approved and passed the resolution for allotment of Equity Shares on conversion of 7,86,690 (Seven Lakhs Eighty-Six Thousand Six Hundred and Ninety Only) warrants into 7,86,690 (Seven Lakhs Eighty-Six Thousand Six Hundred and Ninety Only) Equity Shares at an issue price of Rs. 89/- each (including a premium of Rs. 10/- each), to “Promoters Category”, on preferential basis, upon receipt of balance amount aggregating to Rs. 5,25,11,557.5/- (Rupees Five Crores Twenty-Five Lakhs Eleven Thousand Five Hundred and Fifty-Seven and Paise Fifty Only) being 75% of the issue price per warrant, from the allottees pursuant to the exercise of their rights of conversion into equity shares in accordance with the provisions of SEBI (ICDR) Regulations, 2018 and list of allottees is enclosed as Annexure-A. Pursuant to the approval of Board of Directors at their meeting held on 15th January, 2026 and members approval via Special Resolution at the Extra-ordinary General Meeting (EGM) held on 12th February, 2026 these warrants were issued, in terms of SEBI (ICDR) Regulations, 2018 to “Promoter and Non- Promoters Category”, on preferential basis, at an Issue Price of Rs. 89/- (Rupees Eighty-Nine Only) per warrant on payment of Rs. 22.25/- (Rupees Twenty-Two and Twenty-Five Paise Only) per warrant, being 25% of the Issue Price, entitling the warrants holders to get their warrants converted into equal number of Equity Shares of the Company by paying remaining 75% i.e., Rs. 66.75/- (Rupees Sixty-Six and Seventy-Five Paise Only) per warrant within 18 months from the date of warrant allotment. Consequent to the aforesaid conversion / allotment, the paid-up equity capital of the Company has increased from Rs. 10,12,74,350/- (Rupees Ten Crores Twelve Lakhs Seventy-Four Thousand Three Hundred and Fifty Only) consisting of 1,01,27,435 (One Crore One Lakhs Twenty-Seven Thousand Four Hundred and Thirty-Five Only) Equity Shares of Rs. 10/- (Rupees Ten Only) each to Rs. 10,91,41,250/- (Rupees Ten Crores Ninety-One Lakhs Forty-One Thousand Two Hundred and Fifty Only) consisting of 1,09,14,125 (One Crore Nine Lakhs Fourteen Thousand One Hundred and Twenty- Five Only) Equity Shares of Rs. 10/- (Rupees Two Only) each. GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. The new equity shares so allotted, shall rank pari-passu with the existing equity shares of the Company. It may be noted that 15,73,375 total warrants are outstanding for conversion and these warrant holders are entitled to get their warrants converted into equal number of Equity Shares of the Company by paying remaining 75% i.e., Rs. 66.75/- per warrant within 18 months from the date of warrant allotment. The Company has received In-principal approval from BSE Limited vide their letter No: LOD/PREF/PB/FIP/1795/2025-26 dated 04th March, 2026. Details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 is enclosed as Annexure-B. This is for the information and records of the Exchange, please Thanking you. Yours faithfully, For Godavari Drugs Limited Venkatesh Achanta Company Secretary & Compliance Officer GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. ANNEXURE - A List of Proposed Allottees S No. Name of the Proposed Allottee Equity Shares to be Allotted upon conversion of Warrants Promoter Category 1. Ghanshyam Jaju 60,000.00 2. Kamala Jaju 1,00,000.00 3. Mohit Jaju 1,33,355.00 4. Priyanka Jaju 33334 5. Ieshir Jaju 66667 6. Mukund Kakani 156334 7. Sushma Kakani 141000 8. Tanushree Kakani 46000 9. Aksheit Kakani 50000 Total 7,86,690 GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. ANNEXURE – B Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 S No. Particulars Details 1. Type of securities proposed to be Equity Shares allotted on conversion of fully paid issued (viz. equity shares, Warrants. convertibles etc.); 2. Type of Issuance (further public Preferential allotment, on a private placement basis. Preferential Allotment offering, (Conversion of Warrants into Equity Shares). rights issue, depository receipts (ADR/GDR), qualified institutions placement, preferential allotment etc.) 3. Total number of securities Total number of securities allotted – 7,86,690 proposed to be issued or the total Total amount of securities allotted – amount for which the securities Rs.5,25,11,557.5/- (7,86,690 number of shares * will be issued (approximately) Rs. 66.75/- paid per share) 4. Names of the investors As per Annexure - A 5. Post allotment of securities - Post the conversion of warrants into equity shares, outcome of the subscription, issue the paid-up equity share capital of the Company has price / allotted price (in case of increased from Rs. 10,12,74,350/- (Rupees Ten convertibles), number of investors Crores Twelve Lakhs Seventy-Four Thousand Three Hundred and Fifty Only) consisting of 1,01,27,435 (One Crore One Lakhs Twenty-Seven Thousand Four Hundred and Thirty-Five Only) Equity Shares of Rs. 10/- (Rupees Ten Only) each to Rs. 10,91,41,250/- (Rupees Ten Crores Ninety- One Lakhs Forty-One Thousand Two Hundred and Fifty Only) consisting of 1,09,14,125 (One Crore Nine Lakhs Fourteen Thousand One Hundred and Twenty-Five Only) Equity Shares of Rs. 10/- (Rupees Two Only) each. Allotment of 7,86,690 Equity Shares of Face Value of Rs. 10/- each fully paid up upon conversion of Warrants. 6. In case of convertibles - Exercise by conversion of 7,86,690 Warrants into intimation on conversion of 7,86,690 fully paid-up Equity Shares. securities or on lapse of the tenure of the instrument